4th Edition of International Conference on Probiotics and Prebiotics
March 26-28, 2026
Probiotics in Disease Prevention and Management
Probiotics in disease prevention and management offer a natural and effective approach to maintaining health and treating various conditions. They have been shown to help manage chronic diseases such as type 2 diabetes, by improving gut health and insulin sensitivity. Probiotics also play a key role in managing conditions related to the gut-brain axis, such as anxiety and depression, by modulating gut microbiota and influencing neurotransmitter production. Additionally, probiotics can be used to prevent antibiotic-associated diarrhea and restore balance to the microbiome after antibiotic treatments. Their therapeutic potential extends to preventing allergies, skin conditions, and even cardiovascular diseases, making probiotics an essential component in disease prevention and management strategies.
Dipak P Ramji
Cardiff University, United Kingdom
Giuseppinella Melita
University of Study Messina, Italy
Jason Ryan
Sacco System, Australia
Najat Amharar
Burjeel, United Arab Emirates
Hazal Kibar Demirhan
Ankara University, Turkey
Euller Fernandes Lopes
University of Brasília, Brazil
Veronica Donato
Northeastern University, United StatesSubmit your abstract Today
Title : Overcoming manufacturing challenges in next-generation probiotics: From anaerobic cultivation to clinical-grade formulation
Jason Ryan, Sacco System, Australia
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: State-of-the-art and new insights
Giuseppinella Melita, University of Study Messina, Italy
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Potential for prebiotic food supplement production from by-products of dried persimmon (Diospyros kaki)
Yasin Ozdemir, Ataturk Horticultural Central Research Institute, Turkey